ABYNTEK | Tumor markers for cancer research: FAQS
Tumor Marker:- Part 11 - Carcinoembryonic Antigen (CEA) - Labpedia.net
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
CEA in Activated Macrophages. New Diagnostic Possibilities for Tumor Markers in Early Colorectal Cancer | Anticancer Research
Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Impact of Different Selectivity between Soluble and Membrane-bound Forms of Carcinoembryonic Antigen (CEA) on the Target-mediated Disposition of Anti-CEA Monoclonal Antibodies | Drug Metabolism & Disposition
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer - ScienceDirect
Alteration of tumor markers may predict survival in colorectal cancer patients treated with TAS-102 or regorafenib as salvage-line chemotherapy: a single-institutional experience
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
The effect of visceral fat on the hemodilution effect of serum carcinoembryonic antigen in Korean population | PLOS ONE
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy - Annals of Oncology
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study - Tong - 2018 - Cancer Medicine - Wiley Online Library
Understanding The CEA Test in Colon Cancer - CancerConnect
Frontiers | Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer
Clinical Utility of Tumor Markers
Alteration of tumor markers may predict survival in colorectal cancer patients treated with TAS-102 or regorafenib as salvage-line chemotherapy: a single-institutional experience
